IMAC Holdings to Present at The LD 500 (Virtual)

LOS ANGELES, CA / ACCESSWIRE / July 21, 2020 / IMAC Holdings, Inc. (NASDAQ:IMAC), a provider of innovative medical advancements and care specializing in regenerative rehabilitation orthopedic treatments without the use of surgery or opioids, today announced that it will be presenting at the LD 500 on Tuesday, September 1st at 9:00 AM ET/ 6:00 AM PT. CEO, Jeff Ervin will be presenting to a live audience.

Register here: https://ld-micro-conference.events.issuerdirect.com/

“We are honored to have IMAC present again on our platform. Even being right, smack dab in a global pandemic, the need for medical services has never been greater. It will be interesting to see how IMAC navigates the world we are in today and provides therapies and treatments for those of us in physical pain,” stated Chris Lahiji, Founder of LD.

The LD 500 will take place on September 1st through the 4th.

View IMAC’s profile here: http://www.ldmicro.com/profile/IMAC

The company will also be webcasting its presentation, which can be accessed via
https://www.webcaster4.com/Webcast/Page/2019/36051.

Profiles powered by LD Micro – News Compliments of ACCESSWIRE

About IMAC Holdings, Inc.

IMAC Holdings was created in March 2015 to expand on the footprint of the original IMAC Regeneration Center, which opened in Kentucky in August 2000. IMAC Regeneration Centers combine life science advancements with traditional medical care for movement restricting diseases and conditions. IMAC owns or manages 15 outpatient clinics that provide regenerative, orthopedic and minimally invasive procedures and therapies. It has partnered with several active and former professional athletes, opening six Ozzie Smith IMAC Regeneration Centers, two David Price IMAC Regeneration Centers, as well as Mike Ditka IMAC Regeneration Centers and a Tony Delk IMAC Regeneration Center. IMAC’s outpatient medical clinics emphasize its focus around treating sports and orthopedic injuries and movement-restricting diseases without surgery or opioids. More information about IMAC Holdings, Inc. is available at www.imacregeneration.com.

About LD Micro

Back in 2006, LD Micro began with the sole purpose of being an independent resource to the microcap world.

What started as a newsletter highlighting unique companies, has transformed into the pre-eminent event platform in the space.

The upcoming “500” in September is the Company’s most ambitious project yet, and the first event that can be accessed by anyone.

For those interested in attending, please contact David Scher at david@ldmicro.com or visit www.ldmicro.com for more information.

For those with any questions, please contact David Scher at david@ldmicro.com or visit www.ldmicro.com for more information.

Contact:
Investors
Bret Shapiro
(516) 222-2560
brets@coreir.com

SOURCE: IMAC Holdings, Inc. via LD Micro

View source version on accesswire.com:
https://www.accesswire.com/598312/IMAC-Holdings-to-Present-at-The-LD-500-Virtual

Staff

Recent Posts

Cardiol Therapeutics Achieves Key 50% Patient Enrollment Milestone in Pivotal Phase III MAVERIC Trial in Recurrent Pericarditis

Clinical trial infrastructure fully operational in the U.S. with more than 15 leading cardiovascular centers…

31 minutes ago

CannaPharmaRX Provides Corporate Update and Outlines Growth Strategy for 2026

CALGARY, AB / ACCESS Newswire / January 12, 2026 / CannaPharmaRX, Inc. (OTC PINK:CPMD), an…

12 hours ago

TempraMed Closes C$2.5 Million Fully Subscribed Private Placement

Vancouver, British Columbia--(Newsfile Corp. - January 12, 2026) - TempraMed Technologies Ltd. (CSE: VIVI) (FSE:…

14 hours ago

TruuCONNECT NJ Statewide Digital Hub Empowers Users to Find Verified, Local Community Resources and Support – Anonymously and in Real Time

MOUNT LAUREL, N.J., Jan. 12, 2026 /PRNewswire/ -- Born out of a partnership between the…

14 hours ago

Nuvo Unveils Large-Scale AI-Ready Pregnancy Dataset Built on Real-World Maternal and Fetal Physiology

Unique longitudinal dataset combining native fetal and maternal ECG with phonocardiography supports deeper insights into…

14 hours ago

Alamar Biosciences Announces Launch of NULISAqpcr™ AD 5-plex Assay, Advancing Blood Based Biomarker Detection in Alzheimer’s Disease Research

FREMONT, Calif., Jan. 12, 2026 /PRNewswire/ -- Alamar Biosciences, Inc. ("Alamar"), a leader in precision…

15 hours ago